0 valutazioniIl 0% ha trovato utile questo documento (0 voti)
185 visualizzazioni2 pagine
Omeprazole inhibits activity of acid (proton) pump, and binds to hydrogen-potassium adenosine triphosphatase, located at secretory surface of the gastric parietal cells. Contraindicated in patients hypersensitive to drug or its components.
Omeprazole inhibits activity of acid (proton) pump, and binds to hydrogen-potassium adenosine triphosphatase, located at secretory surface of the gastric parietal cells. Contraindicated in patients hypersensitive to drug or its components.
Copyright:
Attribution Non-Commercial (BY-NC)
Formati disponibili
Scarica in formato DOC, PDF, TXT o leggi online su Scribd
Omeprazole inhibits activity of acid (proton) pump, and binds to hydrogen-potassium adenosine triphosphatase, located at secretory surface of the gastric parietal cells. Contraindicated in patients hypersensitive to drug or its components.
Copyright:
Attribution Non-Commercial (BY-NC)
Formati disponibili
Scarica in formato DOC, PDF, TXT o leggi online su Scribd
NAS III – Pharmacology, Therapeutics and Diagnostics
DRUG STUDY
Name of Patient Age Height
Diagnosis Sex Weight Doctor Date of Admission Body Build
Drug Data Classification Mechanism of Action Indication
Generic Name Pharmacologic Class Inhibits activity of acid (proton) pump, and binds to General Indications omeprazole proton pump inhibitors hydrogen-potassium adenosine triphosphatase, Symptomatic gastroesophageal reflux disease located at secretory surface of the gastric parietal (GERD) without esophageal lesions Trade Name Therapeutic Class cells, to block formation of gastric acid. Erosive esophagitis and accompanying Losec, Prilosec Antiulcer agents symptoms caused by GERD Pharmacokinetics Maintenance of healing erosive esophagitis Patient’s Dose Pregnancy Risk Category Pathologic hypersecretory conditions (such as C Onset Zollinger-Ellison syndrome) Duodenal ulcer (short-term treatment) Minimum Dose Peak Helicobacter pylori infection and duodenal ulcer disease, to eradicate H. pylori with Duration clarithromycin (dual therapy) Maximum Dose H. pylori infection and duodenal ulcer disease, Drug Half Life to eradicate H. pylori with clarithromycin and amoxicillin (triple therapy) Contents Short-term treatment of active benign gastric Availability ulcer Capsules (delayed-release): 10 mg, 20 mg, 40 mg Patient’s Actual Indication Routes of administration PO Source: Source: Source: Source: Contraindications Adverse Reactions Nursing Responsibilities Contraindicated in: CNS: headache, dizziness, asthenia Before Contraindicated in patients hypersensitive to Assess patient’s history: Hypersensitivity to omeprazole or drug or its components. GI: diarrhea, abdominal pain, nausea, vomiting, any of its components; pregnancy, lactation constipation, flatulence Precaution Conduct physical assessment: Skin lesions; T; reflexes, affect; urinary output, abdominal exam; respiratory Use cautiously with pregnancy, lactation Musculoskeletal: back pain auscultation Drug interaction Respiratory: cough, upper respiratory tract infection Dosage adjustments aren't needed for patients with renal Drug-drug. or hepatic impairment. Ampicillin esters, iron derivatives, Skin: rash Omeprazole increases its own bioavailability with repeated ketoconazole: may exhibit poor bioavailability dosages. Drug is labile in gastric acid; less drug is lost to in patients taking omeprazole because hydrolysis because drug increases gastric pH. optimal absorption of these drugs needs a Don't confuse Prilosec with Prozac, Prilocaine, or Prinivil. low gastric pH. Avoid using together. During Diazepam, phenytoin, warfarin: decreases Tell patient to swallow capsules whole and not to open, hepatic clearance, possibly leading to crush, or chew them. increased serum levels. Monitor closely. Administer drug 30 minutes before meals. Drug-herb. Administer antacids with omeprazole, if needed. Male fern: male fern is inactivated in alkaline environments. Patient should separate After administration. Pennyroyal: may change rate of formation of Caution patient not to perform hazardous activities if toxic metabolites of pennyroyal. Avoid using dizziness occurs together. Arrange for further evaluation of patient after 8 wks of therapy for gastroreflux disorders; not intended for maintenance therapy. Instruct patient to have regular medical follow-up visits. Inform patient of the possible side effects of drug and advise to consult with your health care provider if uncomfortable Advise patient to report severe headache, worsening of symptoms, fever, and chills.